Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1982 Mar;79(5):1373–1377. doi: 10.1073/pnas.79.5.1373

Acceleration of the adipocyte adenylate cyclase turn-off reaction by inhibitory hormonal factors.

K H Jakobs, K Aktories, G Shultz
PMCID: PMC345975  PMID: 6951182

Abstract

beta-Adrenergic agonists such as isoproterenol stimulate hamster adipocyte adenylate cyclase by a GTP-dependent process, whereas prostaglandin E1, alpha-adrenergic agonists, and nicotinic acid inhibit the enzyme by a process also dependent on GTP and amplified by sodium ions. We have determined the first-order rate constant describing the decay of isoproterenol plus GTP-stimulated adenylate cyclase and the modulation of this off rate constant by sodium and inhibitory hormonal factors. With 1 microM GTP and 0.2 mM isoproterenol, the off rate constant was 5.0 min-1 at 25 degrees C. Addition of NaCl (100 mM), which increased basal and isoproterenol-stimulated cyclase activities, decreased the rate constant of the hormone-stimulated enzyme to 1.4 min-1. Prostaglandin E1 (10 microM) and nicotinic acid (30 microM), which decreased basal and hormonally stimulated enzyme activities, increased the NaCl-suppressed off rate constant to 6.1 and 6.0 min-1, respectively. Similar data were obtained with 1 mM isoproterenol with MnATP and MgATP as the adenylate cyclase substrate. On the other hand, the turn-on reaction of adipocyte adenylate cyclase, measured with the stable GTP analogue 5'-guanylyl imidodiphosphate (30 microM), was accelerated by isoproterenol (1 mM) and NaCl (100 mM). Under all of these conditions, inhibitory hormonal agents did not cause any delay in the turn-on reaction. These data indicate that, in hamster adipocyte membranes, inhibitory hormonal factors inhibit adenylate cyclase by increasing the enzyme's turn-off reaction.

Full text

PDF
1373

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramowitz J., Iyengar R., Birnbaumer L. Guanyl nucleotide regulation of hormonally-responsive adenylyl cyclases. Mol Cell Endocrinol. 1979 Dec;16(3):129–146. doi: 10.1016/0303-7207(79)90022-4. [DOI] [PubMed] [Google Scholar]
  2. Aktories K., Jakobs K. H. Epinephrine inhibits adenylate cyclase and stimulates a GTPase in human platelet membranes via alpha-adrenoceptors. FEBS Lett. 1981 Aug 3;130(2):235–238. doi: 10.1016/0014-5793(81)81128-3. [DOI] [PubMed] [Google Scholar]
  3. Aktories K., Jakobs K. H., Schultz G. Nicotinic acid inhibits adipocyte adenylate cyclase in a hormone--like manner. FEBS Lett. 1980 Jun 16;115(1):11–14. doi: 10.1016/0014-5793(80)80715-0. [DOI] [PubMed] [Google Scholar]
  4. Aktories K., Schultz G., Jakobs K. H. Inhibition of hamster fat cell adenylate cyclase by prostaglandin e1 and epinephrine: requirement for GTP and sodium ions. FEBS Lett. 1979 Nov 1;107(1):100–104. doi: 10.1016/0014-5793(79)80472-x. [DOI] [PubMed] [Google Scholar]
  5. Aktories K., Schultz G., Jakobs K. H. Regulation of adenylate cyclase activity in hamster adipocytes. Inhibition by prostaglandins, alpha-adrenergic agonists and nicotinic acid. Naunyn Schmiedebergs Arch Pharmacol. 1980 Jun;312(2):167–173. doi: 10.1007/BF00569726. [DOI] [PubMed] [Google Scholar]
  6. Arad H., Levitzki A. The mechanism of partial agonism in the beta-receptor dependent adenylate cyclase of turkey erythrocytes. Mol Pharmacol. 1979 Nov;16(3):749–756. [PubMed] [Google Scholar]
  7. Cassel D., Eckstein F., Lowe M., Selinger Z. Determination of the turn-off reaction for the hormone-activated adenylate cyclase. J Biol Chem. 1979 Oct 10;254(19):9835–9838. [PubMed] [Google Scholar]
  8. Cassel D., Levkovitz H., Selinger Z. The regulatory GTPase cycle of turkey erythrocyte adenylate cyclase. J Cyclic Nucleotide Res. 1977 Dec;3(6):393–406. [PubMed] [Google Scholar]
  9. Cassel D., Selinger Z. Catecholamine-stimulated GTPase activity in turkey erythrocyte membranes. Biochim Biophys Acta. 1976 Dec 8;452(2):538–551. doi: 10.1016/0005-2744(76)90206-0. [DOI] [PubMed] [Google Scholar]
  10. Cassel D., Selinger Z. Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3307–3311. doi: 10.1073/pnas.74.8.3307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cassel D., Selinger Z. Mechanism of adenylate cyclase activation through the beta-adrenergic receptor: catecholamine-induced displacement of bound GDP by GTP. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4155–4159. doi: 10.1073/pnas.75.9.4155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cooper D. M., Schlegel W., Lin M. C., Rodbell M. The fat cell adenylate cyclase system. Characterization and manipulation of its bimodal regulation by GTP. J Biol Chem. 1979 Sep 25;254(18):8927–8931. [PubMed] [Google Scholar]
  13. Hoffman B. B., Lefkowitz R. J. Radioligand binding studies of adrenergic receptors: new insights into molecular and physiological regulation. Annu Rev Pharmacol Toxicol. 1980;20:581–608. doi: 10.1146/annurev.pa.20.040180.003053. [DOI] [PubMed] [Google Scholar]
  14. Jakobs K. H., Aktories K., Schultz G. GTP-dependent inhibition of cardiac adenylate cyclase by muscarinic cholinergic agonists. Naunyn Schmiedebergs Arch Pharmacol. 1979 Dec;310(2):113–119. doi: 10.1007/BF00500275. [DOI] [PubMed] [Google Scholar]
  15. Jakobs K. H., Aktories K. The hamster adipocyte adenylate cyclase system. I. Regulation of enzyme stimulation and inhibition by manganese and magnesium ions. Biochim Biophys Acta. 1981 Aug 5;676(1):51–58. doi: 10.1016/0304-4165(81)90008-8. [DOI] [PubMed] [Google Scholar]
  16. Jakobs K. H., Aktories K. The hamster adipocyte adenylate cyclase system. I. Regulation of enzyme stimulation and inhibition by manganese and magnesium ions. Biochim Biophys Acta. 1981 Aug 5;676(1):51–58. doi: 10.1016/0304-4165(81)90008-8. [DOI] [PubMed] [Google Scholar]
  17. Jakobs K. H. Inhibition of adenylate cyclase by hormones and neurotransmitters. Mol Cell Endocrinol. 1979 Dec;16(3):147–156. doi: 10.1016/0303-7207(79)90023-6. [DOI] [PubMed] [Google Scholar]
  18. Jakobs K. H., Saur W., Schultz G. Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine. J Cyclic Nucleotide Res. 1976 Nov-Dec;2(6):381–392. [PubMed] [Google Scholar]
  19. Jakobs K. H., Schultz G. Different inhibitory effect of adrenaline on platelet adenylate cyclase in the presence of GTP plus cholera toxin and of stable GTP analogues. Naunyn Schmiedebergs Arch Pharmacol. 1979 Dec;310(2):121–127. doi: 10.1007/BF00500276. [DOI] [PubMed] [Google Scholar]
  20. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  21. Mellwig K. P., Jakobs K. H. Inhibition of platelet adenylate cyclase by ADP. Thromb Res. 1980 Apr 1;18(1-2):7–17. doi: 10.1016/0049-3848(80)90166-8. [DOI] [PubMed] [Google Scholar]
  22. Rodbell M. The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature. 1980 Mar 6;284(5751):17–22. doi: 10.1038/284017a0. [DOI] [PubMed] [Google Scholar]
  23. Ross E. M., Gilman A. G. Biochemical properties of hormone-sensitive adenylate cyclase. Annu Rev Biochem. 1980;49:533–564. doi: 10.1146/annurev.bi.49.070180.002533. [DOI] [PubMed] [Google Scholar]
  24. Sabol S. L., Nirenberg M. Regulation of adenylate cyclase of neuroblastoma x glioma hybrid cells by alpha-adrenergic receptors. I. Inhibition of adenylate cyclase mediated by alpha receptors. J Biol Chem. 1979 Mar 25;254(6):1913–1920. [PubMed] [Google Scholar]
  25. Steer M. L., Wood A. Regulation of human platelet adenylate cyclase by epinephrine, prostaglandin E1, and guanine nucleotides. Evidence for separate guanine nucleotide sites mediating stimulation and inhibition. J Biol Chem. 1979 Nov 10;254(21):10791–10797. [PubMed] [Google Scholar]
  26. Walseth T. F., Johnson R. A. The enzymatic preparation of [alpha-(32)P]nucleoside triphosphates, cyclic [32P] AMP, and cyclic [32P] GMP. Biochim Biophys Acta. 1979 Mar 28;562(1):11–31. doi: 10.1016/0005-2787(79)90122-9. [DOI] [PubMed] [Google Scholar]
  27. Watanabe A. M., McConnaughey M. M., Strawbridge R. A., Fleming J. W., Jones L. R., Besch H. R., Jr Muscarinic cholinergic receptor modulation of beta-adrenergic receptor affinity for catecholamines. J Biol Chem. 1978 Jul 25;253(14):4833–4836. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES